0      0

JL1129ES - JL1129ES: Symptoms and Impacts Important to Patients With Advanced/Metastatic Non-small Cell Lung Cancer (Adv/Met NSCLC): Results of a Qualitative Research Study

‐ Oct 25, 2023 4:00pm

Full author listing Authors: Cardellino, A, MPH1; Shah, M, MPH1; Hanlon, J, MPH2*; Taiyari, S, MSc3; Kelly, K, PhD4; Roborel de Climens, A, PhD5; Stojadinovic, A, MD1*

Affiliations: 1GSK, Collegeville, PA, USA; 2GSK, Waltham, MA, USA; 3GSK, Stevenage, UK; 4IQVIA, New York, USA; 5IQVIA, Paris, France

*Affiliation at the time of the study


You must be logged in and own this session in order to post comments.